Ascorbic acid PEG-2L is superior for early morning colonoscopies in colorectal cancer screening programs: a prospective non-randomized controlled trial.
Rodríguez de Miguel C, Serradesanferm A, López-Cerón M, Carballal S, Pozo A, Balaguer F, Cárdenas A, Fernández-Esparrach G, Ginés A, González-Suárez B, Moreira L, Ordás I, Ricart E, Sendino O, Vaquero EC, Ubré M, del Manzano S, Grau J, Llach J, Castells A, Pellisé M; PROCOLON group.
Rodríguez de Miguel C, et al.
Gastroenterol Hepatol. 2015 Feb;38(2):62-70. doi: 10.1016/j.gastrohep.2014.09.007. Epub 2014 Oct 29.
Gastroenterol Hepatol. 2015.
PMID: 25458542
Clinical Trial.